An alternative splicing signature in human Crohn’s disease

BMC Gastroenterology

Table 1 Clinical Characteristics of the Patients (A total of 4 patients with CD were included between June 2020 and September 2020

	Patient1	Patient2	Patient3	Patient4
Age (years)	16	22	30	23
Gender	Male	Female	Female	Male
Course of disease (years)	1.5	0.5	4	3
Age at diagnosis	15	22	29	21
Disease phenotype	B3	B1	B1p	B2p
Disease location	L3	L3	L3	L2
CDAI	160	170	410	240
Medication	Anti-TNF-a therapy	5-ASA and Anti-TNF-a therapy	Anti-TNF-a therapy	Anti-TNF-a therapy and corticosteroids

The clinical characteristics of all patients are shown in Table 1. There were no significant differences with regard to age and sex between the experimental and control groups (P > 0.05).)
Locations: L1 = terminal ileum; L2 = colon; L3 = ileocolon. Behaviors: B1 = nonstricturing; B2 = stricturing, B3 = penetrating; P = perianal disease
ASA, Aminosalicylic acid

ISSN: 1471-230X